Prostate most cancers is the second main explanation for cancer-related demise in males within the USA; demise happens when sufferers progress to metastatic castration-resistant prostate most cancers (CRPC). Although immunotherapy with the Food and Drug Administration-approved vaccine sipuleucel-T, which targets prostatic acid phosphatase (PAP), extends survival for 2-Four months, the identification of latest immunogenic tumor-associated antigens (TAAs) continues to be an unmet want.
We evaluated the differential expression profile of castration-resistant prostate epithelial cells that give rise to CRPC from mice following an androgen deprivation/repletion cycle. The expression ranges of a set of androgen-responsive genes had been additional evaluated in prostate, mind, colon, liver, lung, pores and skin, kidney, and salivary gland from murine and human databases.
The expression of a novel prostate-restricted TAA was then validated by immunostaining of mouse tissues and analyzed in major tumors throughout all human most cancers varieties in The Cancer Genome Atlas. Finally, the immunogenicity of this TAA was evaluated in vitro and in vivo utilizing autologous coculture assays with cells from wholesome donors in addition to by measuring antigen-specific antibodies in sera from sufferers with prostate most cancers (PCa) from a neoadjuvant scientific trial.
We recognized a set of androgen-responsive genes that might function potential TAAs for PCa. In specific, we discovered transglutaminase 4 (Tgm4) to be extremely expressed in prostate tumors that originate from luminal epithelial cells and solely expressed at low ranges in most extraprostatic tissues evaluated. Furthermore, elevated ranges of TGM4 expression in major PCa tumors correlated with unfavorable prognosis in sufferers. In vitro and in vivo assays confirmed the immunogenicity of TGM4.
We discovered that activated proinflammatory effector reminiscence CD8 and CD4 T cells had been expanded by monocyte-derived dendritic cell (moDCs) pulsed with TGM4 to a larger extent than moDCs pulsed with both PAP or prostate-specific antigen (PSA), and T cells primed with TGM4-pulsed moDCs produce practical cytokines following a major/enhance regiment or in vitro stimulation.
An IgG antibody response to TGM4 was detected in 30% of vaccinated sufferers, whereas fewer than 8% of vaccinated sufferers developed antibody responses to PSA or prostate-specific membrane antigen (PSMA).
Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced through antigen elimination obtain excessive in vivo patency charges
Diseases of small diameter blood vessels embody the biggest portion of cardiovascular illnesses, with over 4.2 million folks present process autologous vascular grafting yearly. However, roughly one third of sufferers are ineligible for autologous vascular grafting resulting from lack of appropriate donor vasculature. Acellular extracellular matrix (ECM) scaffolds derived from xenogeneic vascular tissue have potential to function splendid biomaterials for manufacturing of off-the-shelf vascular graft able to eliminating the necessity for autologous vessel harvest.
A modified antigen elimination tissue (AR) course of, using aminosulfabetaine-16 (ASB-16) was used to create off-the-shelf small diameter (< three mm) vascular graft from bovine saphenous vein ECM scaffolds with considerably lowered antigenic content material, whereas retaining native vascular ECM protein construction and performance.
Elimination of native tissue antigen content material conferred graft-specific adaptive immune avoidance, whereas retention of native ECM protein macromolecular construction resulted in pro-regenerative mobile infiltration, ECM turnover and innate immune self-recognition in a rabbit subpannicular mannequin. Finally, retention of the fragile vascular basement membrane protein integrity conferred endothelial cell repopulation and 100% patency fee in a rabbit jugular interposition mannequin, comparable solely to Autograft implants.
Alternatively, the dearth of those necessary basement membrane proteins in in any other case similar scaffolds yielded a patency fee of solely 20%. We conclude that acellular antigen eliminated bovine saphenous vein ECM scaffolds have potential to function splendid off-the-shelf small diameter vascular scaffolds with excessive in vivo patency charges resulting from their low antigen content material, retained native tissue basement membrane integrity and preserved native ECM construction, composition and practical properties.
Nanoparticle Transfer Biosensors for the Non-Invasive Detection of SARS-CoV-2 Antigens Trapped in Surgical Face Masks
Detecting SARS-CoV-2 antigens in respiratory tract samples has turn out to be a widespread methodology for screening new SARS-CoV-2 infections. This requires a nasopharyngeal swab carried out by a skilled healthcare employee, which places pressure on saturated healthcare providers. In this manuscript we describe a brand new strategy for non-invasive COVID-19 analysis.
It consists of utilizing cellular biosensors for detecting viral antigens trapped in surgical face masks worn by sufferers. The biosensors are product of filter paper containing a nanoparticle reservoir. The nanoparticles switch from the biosensor to the masks on contact, the place they generate colorimetric indicators which might be quantified with a smartphone app.
Sample assortment requires sporting a surgical masks for 30 minutes, and the overall assay time is shorter than 10 min. When examined in a cohort of 27 sufferers with gentle or no signs, an space below the receiving working curve (AUROC) of 0.99 was obtained (96.2% sensitivity and 100% specificity). Serial measurements revealed a excessive sensitivity and specificity when masks had been worn as much as 6 days after analysis.
Surgical face masks are cheap and extensively accessible, which makes this strategy simple to implement wherever. Recent SARS-CoV-2 outbreak has been declared as a world well being emergency. It takes years to vaccinate the entire inhabitants to guard them from this lethal virus, therefore the administration of SARS-CoV-2 largely depends upon the widespread availability of an correct diagnostic check.
Towards addressing the unmet want of a dependable diagnostic check within the present work by using the ability of Systematic Evolution of Ligands by EXponential enrichment, a 44-mer G-quadruplex forming DNA aptamer towards spike trimer antigen of SARS-CoV-2 was recognized.
Rubella virus capsid (C) recombinant antigen |
|||
| 00217-V-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: Rubella virus capsid (C) recombinant antigen a.a. 1-123. |
|||
Rubella virus capsid (C) recombinant antigen |
|||
| 00217-V-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: Rubella virus capsid (C) recombinant antigen a.a. 1-123. |
|||
Rubella virus capsid (C) recombinant antigen a.a. 1-123. |
|||
| 00217-V-100ugvial | Virogen | 100 ug/vial | 150 EUR |
|
Description: Rubella virus capsid (C) recombinant antigen a.a. 1-123. |
|||
Rubella virus antibody |
|||
| 10R-R119a | Fitzgerald | 1 mg | 444 EUR |
|
Description: Mouse monoclonal Antibody raised against Rubella virus |
|||
Rubella virus antibody |
|||
| 20-RG04 | Fitzgerald | 1 ml | 440.4 EUR |
|
Description: Goat polyclonal Rubella virus antibody |
|||
Rubella Virus Antibody |
|||
| abx023129-1ml | Abbexa | 1 ml | 644.4 EUR |
Rubella Virus E1 Antibody |
|||
| abx022204-1mg | Abbexa | 1 mg | 718.8 EUR |
Rubella Virus E1 Antibody |
|||
| abx022205-1mg | Abbexa | 1 mg | 610.8 EUR |
Rubella Virus E1 Antibody |
|||
| abx022206-1mg | Abbexa | 1 mg | 610.8 EUR |
Rubella Virus Antibody (HRP) |
|||
| abx023126-1ml | Abbexa | 1 ml | 718.8 EUR |
Rubella virus antibody (HRP) |
|||
| 60-RG05 | Fitzgerald | 1 ml | 480 EUR |
|
Description: Goat polyclonal Rubella virus antibody (HRP) conjugated |
|||
Rubella Virus Antibody (FITC) |
|||
| abx023127-1ml | Abbexa | 1 ml | 661.2 EUR |
Rubella virus antibody (FITC) |
|||
| 60-RG04 | Fitzgerald | 1 ml | 440.4 EUR |
|
Description: Goat polyclonal Rubella virus antibody (FITC) conjugated |
|||
Rubella virus protein |
|||
| 30-1344 | Fitzgerald | 1 ml | 457.2 EUR |
|
Description: Purified native Rubella virus protein (Grade III) |
|||
Rubella Virus Protein |
|||
| abx670270-1mg | Abbexa | 1 mg | 1212 EUR |
Rubella Virus Protein |
|||
| abx670271-1mg | Abbexa | 1 mg | 2163.6 EUR |
Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. |
|||
| 00215-V-100ugvial | Virogen | 100 ug/vial | 150 EUR |
|
Description: Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. |
|||
Rubella virus PCR kit |
|||
| PCR-H481-48R | Bioingentech | 50T | 987.6 EUR |
Rubella virus PCR kit |
|||
| PCR-H481-96R | Bioingentech | 100T | 1335.6 EUR |
Rubella Virus E1 Mosaic |
|||
| PR27125 | Neuromics | 500 ug | 999.6 EUR |
Rubella Virus Capsid C |
|||
| PR27126 | Neuromics | 500 ug | 999.6 EUR |
Rubella Virus E2 Protein |
|||
| 20-abx260148 | Abbexa |
|
|
Rubella virus E2 protein |
|||
| 30-1281 | Fitzgerald | 1 mg | 1585.2 EUR |
|
Description: Purified recombinant Rubella virus E2 protein |
|||
Rubella Virus E1 protein |
|||
| 80-1059 | Fitzgerald | 1 mg | 2058 EUR |
|
Description: Purified recombinant Rubella Virus E1 protein |
|||
Rubella Virus E2 Protein |
|||
| abx060648-1mg | Abbexa | 1 mg | 2055.6 EUR |
Rubella Virus E2 Protein |
|||
| abx060649-1mg | Abbexa | 1 mg | 1713.6 EUR |
Rubella virus E2 protein |
|||
| DAGA-498 | Creative Diagnostics | 1mg | 3385.2 EUR |
Rubella Virus Capsid Protein |
|||
| abx060645-1mg | Abbexa | 1 mg | 2180.4 EUR |
Recombinant Rubella Virus E2 |
|||
| 7-07861 | CHI Scientific | 100µg | Ask for price |
Recombinant Rubella Virus E2 |
|||
| 7-07862 | CHI Scientific | 500µg | Ask for price |
Recombinant Rubella Virus E2 |
|||
| 7-07863 | CHI Scientific | 1000µg | Ask for price |
Rubella virus RT PCR kit |
|||
| RTq-H481-100R | Bioingentech | 100T | 1573.2 EUR |
Rubella virus RT PCR kit |
|||
| RTq-H481-150R | Bioingentech | 150T | 2144.4 EUR |
Rubella virus RT PCR kit |
|||
| RTq-H481-50R | Bioingentech | 50T | 1155.6 EUR |
QPCR Kit RNA Rubella virus |
|||
| MOL8312 | Scientific Laboratory Supplies | EACH | 788.88 EUR |
Rubella Virus E1 protein [GST] |
|||
| DAGA-499 | Creative Diagnostics | 1mg | 4446 EUR |
Rubella Virus Capsid Protein Antibody |
|||
| abx022208-1mg | Abbexa | 1 mg | 610.8 EUR |
Rubella virus protein (Grade 1) |
|||
| 30-1330 | Fitzgerald | 1 ml | 975.6 EUR |
|
Description: Purified Native Rubella virus protein (Grade 1) |
|||
Rubella virus protein (Grade 2) |
|||
| 30-1331 | Fitzgerald | 1 mg | 2018.4 EUR |
|
Description: Purified Native Rubella virus protein (Grade 2) |
|||
Rubella Virus Capsid C Protein |
|||
| 20-abx260149 | Abbexa |
|
|
Rubella Virus E1 Mosaic Protein |
|||
| 20-abx260310 | Abbexa |
|
|
Rubella Virus Capsid C protein |
|||
| 80-1058 | Fitzgerald | 100 ug | 548.4 EUR |
|
Description: Purified recombinant Rubella Virus Capsid C protein |
|||
Rubella Virus E1 Mosaic Protein |
|||
| abx060646-1mg | Abbexa | 1 mg | 2214 EUR |
Rubella Virus E1 Mosaic Protein |
|||
| abx060647-1mg | Abbexa | 1 mg | 1796.4 EUR |
Recombinant Rubella Virus Rubella E1 Protein, GST, E.coli-1mg |
|||
| QP13373-1mg | EnQuireBio | 1mg | 1513.2 EUR |
Rat Rubella virus antibody IgG ELISA Kit |
|||
| ERR0019 | Abclonal | 96Tests | 625.2 EUR |
Rat Rubella virus antibody IgA ELISA Kit |
|||
| ERR0020 | Abclonal | 96Tests | 625.2 EUR |
Rat Rubella virus antibody IgM ELISA Kit |
|||
| ERR0021 | Abclonal | 96Tests | 625.2 EUR |
Recombinant Rubella Virus Rubella E1 Protein, GST, E.coli-100ug |
|||
| QP13373-100ug | EnQuireBio | 100ug | 261.6 EUR |
Recombinant Rubella Virus Rubella E1 Protein, GST, E.coli-500ug |
|||
| QP13373-500ug | EnQuireBio | 500ug | 795.6 EUR |
Mouse Rubella virus antibody IgG ELISA Kit |
|||
| EMR0019 | Abclonal | 96Tests | 625.2 EUR |
Mouse Rubella virus antibody IgA ELISA Kit |
|||
| EMR0020 | Abclonal | 96Tests | 625.2 EUR |
Mouse Rubella virus antibody IgM ELISA Kit |
|||
| EMR0021 | Abclonal | 96Tests | 625.2 EUR |
Human Rubella virus antibody IgG ELISA Kit |
|||
| EHR0019 | Abclonal | 96Tests | 625.2 EUR |
Human Rubella virus antibody IgA ELISA Kit |
|||
| EHR0020 | Abclonal | 96Tests | 625.2 EUR |
Human Rubella virus antibody IgM ELISA Kit |
|||
| EHR0021 | Abclonal | 96Tests | 625.2 EUR |
Bovine Rubella Virus Antibody IgG ELSA KIT |
|||
| QY-E60087 | Qayee Biotechnology | 96T | 511.2 EUR |
Recombinant Rubella Virus Rubella Capsid Protein, GST, E.coli-1mg |
|||
| QP13372-1mg | EnQuireBio | 1mg | 1273.2 EUR |
Recombinant Rubella Virus Rubella E2 Protein, Untagged, E.coli-1mg |
|||
| QP13374-1mg | EnQuireBio | 1mg | 1273.2 EUR |
Recombinant Rubella Virus E1 Mosaic |
|||
| 7-07858 | CHI Scientific | 100µg | Ask for price |
Recombinant Rubella Virus E1 Mosaic |
|||
| 7-07859 | CHI Scientific | 500µg | Ask for price |
Recombinant Rubella Virus E1 Mosaic |
|||
| 7-07860 | CHI Scientific | 1000µg | Ask for price |
Recombinant Rubella Virus Capsid C |
|||
| 7-07864 | CHI Scientific | 100µg | Ask for price |
Recombinant Rubella Virus Capsid C |
|||
| 7-07865 | CHI Scientific | 500µg | Ask for price |
Recombinant Rubella Virus Capsid C |
|||
| 7-07866 | CHI Scientific | 1000µg | Ask for price |
Recombinant Rubella Virus Rubella Capsid Protein, GST, E.coli-100ug |
|||
| QP13372-100ug | EnQuireBio | 100ug | 261.6 EUR |
Recombinant Rubella Virus Rubella Capsid Protein, GST, E.coli-500ug |
|||
| QP13372-500ug | EnQuireBio | 500ug | 795.6 EUR |
Rubella virus One-Step PCR kit |
|||
| Oneq-H481-100R | Bioingentech | 100T | 1932 EUR |
Rubella virus One-Step PCR kit |
|||
| Oneq-H481-150R | Bioingentech | 150T | 2646 EUR |
Rubella virus One-Step PCR kit |
|||
| Oneq-H481-50R | Bioingentech | 50T | 1410 EUR |
Recombinant Rubella Virus Rubella E2 Protein, Untagged, E.coli-100ug |
|||
| QP13374-100ug | EnQuireBio | 100ug | 261.6 EUR |
Recombinant Rubella Virus Rubella E2 Protein, Untagged, E.coli-500ug |
|||
| QP13374-500ug | EnQuireBio | 500ug | 795.6 EUR |
Rubella virus E2 Recombinant Protein |
|||
| 53-354 | ProSci | 0.01 mg | 714.3 EUR |
|
Description: Rubella virus E2 Recombinant Protein |
|||
Rubella virus E1 Recombinant Protein |
|||
| 53-355 | ProSci | 0.01 mg | 714.3 EUR |
|
Description: Rubella virus E1 Recombinant Protein |
|||
Recombinant Rubella Virus E2 Protein |
|||
| DAG514 | Creative Diagnostics | 1mg | 1537.2 EUR |
Goat polyclonal antibody for Rubella virus |
|||
| 1701 | Virostat | 1 ml | 327.53 EUR |
|
Description: This is goat polyclonal antibody against Rubella virus virions for WB, ELISA. |
|||
Goat polyclonal antibody for Rubella virus |
|||
| 1703 | Virostat | 1 ml | 347.1 EUR |
|
Description: This is FITC conjugated goat polyclonal antibody against Rubella virus virions for WB, ELISA. |
|||
Goat polyclonal antibody for Rubella virus |
|||
| 1707 | Virostat | 1 ml | 347.1 EUR |
|
Description: This is Biotin conjugated goat polyclonal antibody against Rubella virus virions for WB, ELISA. |
|||
Goat polyclonal antibody for Rubella virus |
|||
| 504 | Virostat | 1 ml | 373.2 EUR |
|
Description: This is HRP conjugated goat polyclonal antibody against Rubella virus virions for WB, ELISA. |
|||
Mouse Anti Rubella Virus Monoclonal Antibody |
|||
| DMABT-51535MR | Creative Diagnostics | 0.2 mg | 795.6 EUR |
Human Rubella Virus IgM Antibody ELISA Kit |
|||
| abx364857-96tests | Abbexa | 96 tests | 548.4 EUR |
Human Rubella Virus IgG Antibody ELISA Kit |
|||
| abx364858-96tests | Abbexa | 96 tests | 548.4 EUR |
Human Rubella Virus IgG Antibody ELISA Kit |
|||
| abx053898-96tests | Abbexa | 96 tests | 801.6 EUR |
Human Rubella Virus IgM Antibody ELISA Kit |
|||
| abx054089-96tests | Abbexa | 96 tests | 801.6 EUR |
Recombinant Rubella Virus Capsid (33 kDa) |
|||
| DAG494 | Creative Diagnostics | 1mg | 1731.6 EUR |
Recombinant (E.Coli) Rubella Virus E2 protein |
|||
| RP-1414 | Alpha Diagnostics | 100 ug | 343.2 EUR |
Goat Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| EGTR0019 | Abclonal | 96Tests | 625.2 EUR |
Goat Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| EGTR0020 | Abclonal | 96Tests | 625.2 EUR |
Goat Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| EGTR0021 | Abclonal | 96Tests | 625.2 EUR |
Mouse Rubella Virus Antibody IgG(RV-IgG )ELSA KIT |
|||
| QY-E21685 | Qayee Biotechnology | 96T | 448.8 EUR |
Mouse antibody for Rubella virus E1 glycoprotein |
|||
| 1712 | Virostat | 100 ug | 386.26 EUR |
|
Description: This is purified Mouse monoclonal antibody against Rubella virus E1 glycoprotein for WB, ELISA. |
|||
Mouse antibody for Rubella virus E1 glycoprotein |
|||
| 1714 | Virostat | 100 ug | 386.26 EUR |
|
Description: This is purified Mouse monoclonal antibody against Rubella virus E1 glycoprotein for WB, ELISA. |
|||
Mouse antibody for Rubella virus E1 glycoprotein |
|||
| 1715 | Virostat | 100 ug | 386.26 EUR |
|
Description: This is purified Mouse monoclonal antibody against Rubella virus E1 glycoprotein for WB, ELISA. |
|||
Mouse antibody for Rubella virus E2 glycoprotein |
|||
| 1717 | Virostat | 100 ug | 386.26 EUR |
|
Description: This is purified Mouse monoclonal antibody against Rubella virus E2 glycoprotein for WB, ELISA. |
|||
Rabbit Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| ERTR0019 | Abclonal | 96Tests | 625.2 EUR |
Rabbit Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| ERTR0020 | Abclonal | 96Tests | 625.2 EUR |
Rabbit Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| ERTR0021 | Abclonal | 96Tests | 625.2 EUR |
Bovine Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| EBR0019 | Abclonal | 96Tests | 625.2 EUR |
Bovine Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| EBR0020 | Abclonal | 96Tests | 625.2 EUR |
Bovine Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| EBR0021 | Abclonal | 96Tests | 625.2 EUR |
Canine Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| ECR0019 | Abclonal | 96Tests | 625.2 EUR |
Canine Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| ECR0020 | Abclonal | 96Tests | 625.2 EUR |
Canine Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| ECR0021 | Abclonal | 96Tests | 625.2 EUR |
Porcine Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| EPR0019 | Abclonal | 96Tests | 625.2 EUR |
Porcine Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| EPR0020 | Abclonal | 96Tests | 625.2 EUR |
Porcine Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| EPR0021 | Abclonal | 96Tests | 625.2 EUR |
Recombinant Rubella Virus E1 mosaic (32 kDa) |
|||
| DAG507 | Creative Diagnostics | 1mg | 1725.6 EUR |
Anserine Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| EAR0019 | Abclonal | 96Tests | 625.2 EUR |
Anserine Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| EAR0020 | Abclonal | 96Tests | 625.2 EUR |
Anserine Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| EAR0021 | Abclonal | 96Tests | 625.2 EUR |
Human Rubella Virus (RV) IgG Rapid Test Kit |
|||
| abx092097-20tests | Abbexa | 20 tests | 260.4 EUR |
Guinea Pig Rubella virus antibody IgG ELSA KIT ELISA Kit |
|||
| EGR0019 | Abclonal | 96Tests | 625.2 EUR |
Guinea Pig Rubella virus antibody IgA ELSA KIT ELISA Kit |
|||
| EGR0020 | Abclonal | 96Tests | 625.2 EUR |
Guinea Pig Rubella virus antibody IgM ELSA KIT ELISA Kit |
|||
| EGR0021 | Abclonal | 96Tests | 625.2 EUR |
Recombinant Rubella Virus E1 Mosaic, His-tagged |
|||
| DAG488 | Creative Diagnostics | mg | 1452 EUR |
Recombinant (E.Coli) Rubella Virus E1 Mosaic protein |
|||
| RP-1413 | Alpha Diagnostics | 100 ug | 343.2 EUR |
Recombinant (E.Coli) Rubella Virus Capsid C protein |
|||
| RP-1415 | Alpha Diagnostics | 100 ug | 343.2 EUR |
Mouse Anti Rubella Virus Capsid Protein Monoclonal Antibody |
|||
| DMABT-51537MR | Creative Diagnostics | 0.2 mg | 920.4 EUR |
Mouse Anti Rubella Virus Glycoprotein E1 Monoclonal Antibody |
|||
| DMABT-51538MR | Creative Diagnostics | 0.2 mg | 795.6 EUR |
Mouse Anti Rubella Virus Glycoprotein E2 Monoclonal Antibody |
|||
| DMABT-51540MR | Creative Diagnostics | 0.2 mg | 920.4 EUR |
Rubella BR2S Antigen |
|||
| 30-1979 | Fitzgerald | 1 mg | 1524 EUR |
QPCR Kit RNA Rubella virusMmix |
|||
| MOL8314 | Scientific Laboratory Supplies | EACH | 1010.04 EUR |
Rubella Grade IV Antigen (Strain HPV77) Protein |
|||
| abx069928-1mg | Abbexa | 1 mg | 1863.6 EUR |
Rubella Grade IV Antigen (Strain HPV77) Protein |
|||
| abx069929-1mg | Abbexa | 1 mg | 1863.6 EUR |
Rubella Grade III Antigen (Strain HPV77) Protein |
|||
| abx069927-1ml | Abbexa | 1 ml | 526.8 EUR |
Hepatitis A Virus (HAV) Antigens |
|||
| HAV17-N-10 | Alpha Diagnostics | 10 ug | Ask for price |
Human Cytomegalovirus, Toxoplasma, Rubella, Herpes simplex virus type II IgM Rapid Test Kit |
|||
| abx092077-20tests | Abbexa | 20 tests | 410.4 EUR |
Rubella 2-42 Protein |
|||
| abx069921-1mg | Abbexa | 1 mg | 610.8 EUR |
Mumps virus (Enders) proteins/antigens extract |
|||
| MUMS15-N-500 | Alpha Diagnostics | 0.5 ml | 460.8 EUR |
Rubella ELISA Kit |
|||
| 55R-RB025G | Fitzgerald | 96 wells | 361.2 EUR |
|
Description: ELISA kit for detection of Rubella in the research laboratory |
|||
Rabbit Rubella IgG |
|||
| QY-E30313 | Qayee Biotechnology | 96T | 448.8 EUR |
Rubella 2-6 Protein |
|||
| abx069923-1mg | Abbexa | 1 mg | 610.8 EUR |
Rubella IgG ELISA Kit |
|||
| E4666-100 | Biovision | each | 646.8 EUR |
Rubella IgM ELISA Kit |
|||
| E4667-100 | Biovision | each | 646.8 EUR |
Rubella IgM MAX Protein |
|||
| abx160034-1mg | Abbexa | 1 mg | 4202.4 EUR |
Rat Rubella IgG ELISA Kit |
|||
| QY-E11851 | Qayee Biotechnology | 96T | 448.8 EUR |
RV (Rubella Antibody IgM) ELISA test |
|||
| 31 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of RV (Rubella Antibody IgM) |
|||
RV (Rubella Antibody IgG) ELISA test |
|||
| 30 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of RV (Rubella Antibody IgG) |
|||
Mouse Anti-Hepatitis A Virus (whole viral antigens) IgG |
|||
| HAV13-M | Alpha Diagnostics | 100 ul | 578.4 EUR |
RealScreen Rubella IgG ELISA Kit |
|||
| EL030-096 | GenDepot | 96T | 999.6 EUR |
RealScreen Rubella IgM ELISA Kit |
|||
| EL031-096 | GenDepot | 96T | 854.4 EUR |
Hepatitis A Virus (HAV) antigens (FRhk4, inactivated) for ELISA |
|||
| HAV15-N-100 | Alpha Diagnostics | 100 ug | 416.4 EUR |
Rubella RSVP (TM) (Strain HPV77) Protein |
|||
| abx069931-1mg | Abbexa | 1 mg | 2732.4 EUR |
Human Rubella IgG ELISA Kit (Direct EIA) |
|||
| EK7082 | BosterBio | 96wells/kit, with removable strips. | 573.6 EUR |
Human Rubella IgM ELISA Kit (Direct EIA) |
|||
| EK7083 | BosterBio | 96wells/kit, with removable strips. | 573.6 EUR |
Mouse Monoclonal Anti-Hepatitis B Virus (HBsAg;AD & AY Antigens) IgG |
|||
| AB-15010 | Alpha Diagnostics | 100 ug | 416.4 EUR |
Varicella Zoster Virus (VZV/chickenpox) antigens/proteins (Ellen/HF cells) |
|||
| VZV16-N-500 | Alpha Diagnostics | 250 ul | 489.6 EUR |
Rubella IgG/IgM Protein (Strain HPV77) Protein |
|||
| abx160033-1mg | Abbexa | 1 mg | 1830 EUR |
Varicella Zoster Virus (VZV/chickenpox) antigens/proteins (VZ-10/MRC-5 cells) |
|||
| VZV15-N-500 | Alpha Diagnostics | 500 ul | 489.6 EUR |
Recombiant (E. coli) Hepatitis C Virus (Hepatitis C Virus (HCV) Antigens-GST fusion protein (mosaic of several antigenic epitopes) (soluble) |
|||
| HCV36-R | Alpha Diagnostics | each | 343.2 EUR |
Canine Parainfluenza virus (CPiV) antigens (MDCK cells, inactivated, partially pure) for ELISA/Western |
|||
| SEND45-N-100 | Alpha Diagnostics | 100 ug | 562.8 EUR |
Monoclonal Varicella Zoster Virus (VZV/chickenpox) antigens IgG (pan, recognizes several VZV proteins) |
|||
| VZV11-M | Alpha Diagnostics | 100 ug | 578.4 EUR |
Sendai virus/Parainfluenza type 1 antigens (Vero cells, inactivated, partially pure) for ELISA/Western |
|||
| SEND15-N-100 | Alpha Diagnostics | 100 ul | 416.4 EUR |
Sendai virus/Parainfluenza type 3 antigens (Vero cells, inactivated, partially pure) for ELISA/Western |
|||
| SEND35-N-100 | Alpha Diagnostics | 100 ul | 416.4 EUR |
Measles (Rubeola) Virus (Edmonston) proteins/antigen extract |
|||
| MESL15-N-500 | Alpha Diagnostics | 500 ul | 416.4 EUR |
Human Cytomegalovirus IgG / IgM, Toxoplasma IgG / IgM, Rubella IgG Rapid Test Kit |
|||
| abx092078-20tests | Abbexa | 20 tests | 410.4 EUR |
Sendai virus/Parainfluenza type 2 antigens (Vero cells, inactivated, partially pure) for ELISA/Western, Quantitative |
|||
| SEND25-N-100 | Alpha Diagnostics | 100 ul | 416.4 EUR |
Rubeola virus antibody |
|||
| 10R-11509 | Fitzgerald | 100 ug | 540 EUR |
|
Description: Mouse monoclonal Rubeola virus antibody |
|||
Rubeola virus antibody |
|||
| 10R-11510 | Fitzgerald | 100 ug | 540 EUR |
|
Description: Mouse monoclonal Rubeola virus antibody |
|||
Rubeola virus antibody |
|||
| 10R-11511 | Fitzgerald | 100 ug | 540 EUR |
|
Description: Mouse monoclonal Rubeola virus antibody |
|||
Rubeola virus antibody |
|||
| 10R-11512 | Fitzgerald | 100 ug | 540 EUR |
|
Description: Mouse monoclonal Rubeola virus antibody |
|||
Native Zika Virus antigen |
|||
| DAGA-3054 | Creative Diagnostics | 1mg | 1279.2 EUR |
Rubeola (Measles) Virus Antibody |
|||
| abx022211-100ug | Abbexa | 100 ug | 693.6 EUR |
EBV Early Antigens Antibody |
|||
| V2334-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
|||
EBV Early Antigens Antibody |
|||
| V2334-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
|||
EBV Early Antigens Antibody |
|||
| V2334SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
|||
The lead aptamer candidate (S14) was characterised totally for its binding, selectivity, affinity, construction and batch-to-batch variability by using various-biochemical, biophysical, and in silico methods. S14 has demonstrated a low nanomolar Okayd, confirming its tight binding to a spike antigen of SARS-CoV-2. S14 can detect as little as 2 nM of antigen.